Galderma is a global leader in medical solutions for the skin, hair and nails, wholly-owned by Nestlé Skin Health, a subsidiary of Nestlé.
The company has been researching and developing its extensive range of medically-proven solutions since its creation in 1981. It exclusively partners with healthcare professionals to target a variety of dermatological conditions and skin needs.
Headquartered in Lausanne, Switzerland, Galderma has more than 5,000 employees and 35 affiliates around the world. Its products are distributed in over 100 countries. Its 5 state-of-the-art research and development centers and 6 manufacturing facilities are dedicated to providing a wide range of innovative and science-based medical solutions to meet the highest standards of safety and efficacy.
Strategic brands include Epiduo™, Restylane®, Oracea®, Differin®, Mirvaso®, Soolantra®, Loceryl®, Benzac®, Excipial®, Metvix®, Azzalure®, Tri-Luma™, Cetaphil® and Daylong™.
GALDERMA's Sophia Antipolis (France) R&D site is looking to hire a:
Postdoctoral Researcher Immuno-Metabolism
The postdoctoral position is available immediately in the Research Department.
One of the focuses will be to analyze the metabolism and metabolic reprogramming in innate and adaptive immunity upon skin chronic inflammation. The aim of the current project is to discover novel targets involved in skin immune disorders.
Applicants must have a PhD with a strong background in both immunology and metabolism .
The demonstrated ability to work in a team and an innovation-oriented mindset will be important assets for this position.
Salary will be based on experience